دورية أكاديمية

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.

التفاصيل البيبلوغرافية
العنوان: Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
المؤلفون: Fornecker, Luc-Matthieu, Lazarovici, Julien, Aurer, Igor, Casasnovas, René-Olivier, Gac, Anne-Claire, Bonnet, Christophe, Bouabdallah, Krimo, Feugier, Pierre, Specht, Lena, Molina, Lysiane, Touati, Mohamed, Borel, Cécile, Stamatoullas, Aspasia, Nicolas-Virelizier, Emmanuelle, Pascal, Laurent, Lugtenburg, Pieternella, Di Renzo, Nicola, Vander Borght, Thierry, Traverse-Glehen, Alexandra, Dartigues, Peggy, Hutchings, Martin, Versari, Annibale, Meignan, Michel, Federico, Massimo, André, Marc, LYSA-FIL-EORTC Intergroup
المصدر: Journal of Clinical Oncology, 41, 327 - 335 (2023)
بيانات النشر: Lippincott Williams and Wilkins
سنة النشر: 2023
المجموعة: University of Liège: ORBi (Open Repository and Bibliography)
مصطلحات موضوعية: Brentuximab Vedotin, Bleomycin, Vinblastine, Doxorubicin, Dacarbazine, Humans, Adolescent, Young Adult, Adult, Middle Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasm Staging, Treatment Outcome, Hodgkin Disease/diagnostic imaging, Hodgkin Disease/drug therapy, Hodgkin Disease/pathology, Antineoplastic Combined Chemotherapy Protocols, Hodgkin Disease, Oncology, Cancer Research, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie
الوصف: peer reviewed
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0732-183X
1527-7755
العلاقة: urn:issn:0732-183X; urn:issn:1527-7755; https://orbi.uliege.be/handle/2268/299780Test; info:hdl:2268/299780; https://orbi.uliege.be/bitstream/2268/299780/1/Brentuximab%20Vedotin%20Plus%20AVD.pdfTest; scopus-id:2-s2.0-85145669062; info:pmid:35867960
DOI: 10.1200/JCO.21.01281
الإتاحة: https://doi.org/10.1200/JCO.21.01281Test
https://orbi.uliege.be/handle/2268/299780Test
https://orbi.uliege.be/bitstream/2268/299780/1/Brentuximab%20Vedotin%20Plus%20AVD.pdfTest
حقوق: open access ; http://purl.org/coar/access_right/c_abf2Test ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.50CBC6FA
قاعدة البيانات: BASE
الوصف
تدمد:0732183X
15277755
DOI:10.1200/JCO.21.01281